Tenet's Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major Upgrade

Tenet Healthcare Corp. (NYSE: THC ) stock surged Friday after the company reported second-quarter results that beat Wall Street estimates and raised its fiscal 2026 earnings and revenue guidance. 23. 43 billion.

Same-Store Growth Boosts Results Chairman and CEO Saum Sutaria attributed the strong quarter to solid same-store revenue growth and disciplined expense management. “Strong same-store revenue growth and effective expense management drove our fundamental outperformance in the second quarter of 2026 compared to our original assumptions,” Sutaria said. During the earnings call, Sutaria acknowledged ongoing uncertainty around payer mix and insurance enrollment in the Exchanges and Medicaid. However, he said the company’s growth initiatives and cost controls helped offset those headwinds.

3% from a year earlier. Growth was driven by higher same-facility net patient service revenue, facility acquisitions and expanded service lines. 0%. 3% because of higher-acuity procedures and a more favorable service mix.

24 billion, supported by higher adjusted admissions and increased patient acuity. Lower Exchange admissions created an unfavorable payer mix that partially offset the gains. 3% year over year. The increase reflected stronger commercial employer revenue and higher Medicaid supplemental payments, partly offset by weaker Exchange admissions.

68 per share. 88 per share. 3 billion. 0 billion.

Tenet also increased its expectations for acquisitions. Sutaria said the company now expects to spend more than $300 million on mergers and acquisitions in 2026, citing completed ambulatory surgery acquisitions and a strong deal pipeline. 90 at the time of publication on Friday, according to Pro data. Image via Shutterstock Read Also: Jeff Bezos Said ‘I Predict One Day Amazon Will Fail.

Amazon Will Go Bankrupt’ — But the Key to Prolonging That Demise Is to ‘Obsess Over Customers’